City

Condition

Refractory Small Cell Lung Carcinoma (1)

Relapsed Small Cell Lung Cancer (1)

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Virginia Commonwealth University (1)

Collaborator

AbbVie (1)

Intervention

irinotecan 60 mg/m2 (1)

venetoclax (rp2d) (1)

venetoclax 100 mg (1)

venetoclax 200 mg (1)

venetoclax 400 (1)

venetoclax 50 mg (1)

venetoclax 600 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

refractory small cell lung carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed Small Cell Lung Cancer, Refractory Small Cell Lung Carcinoma Trial (Venetoclax 50 MG, Venetoclax 100 MG, Venetoclax 200

Withdrawn

Relapsed Small Cell Lung Cancer
Refractory Small Cell Lung Carcinoma

Venetoclax 50 MG
+6 more

(no location specified)

Mar 1, 2021